Silver Book Fact

Lifetime risk of developing atrial fibrillation for men and women

The lifetime risk of developing atrial fibrillation is around 1 in 4 for both men and women age 40 and older.

Lloyd-Jones D, Wang T, Leip E, Larson M, et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study. Circ. 2004; 110(9): 1042-6. http://circ.ahajournals.org/cgi/content/short/110/9/1042

Reference

Title
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Publication
Circ
Publication Date
2004
Authors
Lloyd-Jones D, Wang T, Leip E, Larson M, et al
Volume & Issue
Volume 110, Issue 9
Pages
1042-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.  
  • Average length of stay for major bleeding complications
    The average length of stay for major bleeding complications is six days.  
  • Average age of AFib patients
    The mean age for atrial fibrillation is 66.8 years in men and 74.6 years in women.  
  • AFib Medicare cost
    Medicare alone is estimated to pay $15.7 billion per year to treat newly diagnosed atrial fibrillation patients.